Regi, an Allergan-backed on-demand beauty booking platform, is being discontinued a little over a year after its launch. An e-mail to customers Thursday announced the platform’s closure, effective ...
Allergan Inc., the Irvine-based drug maker that’s currently the target of a hostile takeover attempt, has been a farm team of sorts when it comes to Orange County’s vibrant drug and medical device ...
Allergan Aesthetics launched its SkinMedica Even & Correct Collection Tuesday morning, featuring a suite of products targeting hyperpigmentation. The company noted that these SkinMedica offerings are ...
Shire rejected a $60 billion bid from the Japanese drugmaker Takeda, while Allergan briefly considered getting into the fray ...
Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world's largest drugmaker. It's also the largest so-called inversion, where an ...
(Reuters) - Allergan Plc's (AGN.N) chief executive on Monday said he was opposed to fundamental changes to the drug company's business strategy, even as its board considers drastic moves like ...
After resisting the idea of asset sales and then committing to offload its women's health unit, Allergan CEO Brent Saunders has changed course again. But the drugmaker still plans to offload its ...
Amid investor pressure to split up its CEO and chairman roles, embattled Allergan is giving in—but only a bit. Allergan will support an investor resolution to split up the jobs, the company said on ...
When the maker of the top-selling arthritis drug says it’s buying a leader in anti-wrinkle treatments, you’d be forgiven if your initial response to the news was that it seems like a match made in ...
AbbVie’s cosmetics and skin care company Allergan Aesthetics is building on its long-term partnership with nonprofit Girls Inc. to further invest in women’s career trajectories in the Science, ...
Breast implant maker Allergan Inc. on Wednesday issued a worldwide recall of its Biocell textured breast implants and tissue expanders due to the risk of a rare type of cancer. The US Food and Drug ...
Allergan Inc., maker of Botox and other drugs, has filed plans with Irvine officials to build a 250,000-square-foot, four-story office tower at its campus near John Wayne Airport. Allergan spokeswoman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results